An engineering and MBA graduate from Keller School of Management and Stanford University, Steve Verschoor is the co-founder and head of sales at GTSP Global. A former worldwide director at Applied Materials, Steve Verschoor is also one of the original co-founders of Molecular Testing Labs which provides pharmacogenetic testing (PGx testing) to robustly enhance patient treatment outcomes.
PGx testing is a critical early step for designing individualized patient treatment plans. This type of testing leverages genetic data to help physicians identify the best medications to prescribe, leaving out those that are likely to cause adverse health consequences for the patient.
While medications are approved to treat diseases not cause adverse health outcomes, individual patient responses to them differ. Factors like a patient’s age, diet, lifestyle choices, and genetic makeup all impact how his or her body will react to the medication. PGx testing enables doctors to identify patients’ unique genetic structures, informing medication therapy choices.
Besides medication therapy, PGx testing can also support effective post-operative pain relief. Post-surgery, many patients experience pain. If inadequately managed, this pain can spiral into chronic pain, delaying recovery, and even prompting patients to postpone follow up surgeries, exacerbating their illnesses. PGx testing can pinpoint the genetic variations that impact how well pain medication is activated or deactivated in the body, facilitating effective postoperative pain relief and bettering treatment outcomes.
PGx testing is a critical early step for designing individualized patient treatment plans. This type of testing leverages genetic data to help physicians identify the best medications to prescribe, leaving out those that are likely to cause adverse health consequences for the patient.
While medications are approved to treat diseases not cause adverse health outcomes, individual patient responses to them differ. Factors like a patient’s age, diet, lifestyle choices, and genetic makeup all impact how his or her body will react to the medication. PGx testing enables doctors to identify patients’ unique genetic structures, informing medication therapy choices.
Besides medication therapy, PGx testing can also support effective post-operative pain relief. Post-surgery, many patients experience pain. If inadequately managed, this pain can spiral into chronic pain, delaying recovery, and even prompting patients to postpone follow up surgeries, exacerbating their illnesses. PGx testing can pinpoint the genetic variations that impact how well pain medication is activated or deactivated in the body, facilitating effective postoperative pain relief and bettering treatment outcomes.
